|
1
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goggins WB and Wong GK: Poor survival for
US Pacific Islander cancer patients: Evidence from the
surveillance, epidemiology, and end results database: 1991 to 2004.
J Clin Oncol. 25:5738–5741. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei
WQ, Qiao YL and Inoue M: Comparative epidemiology of gastric cancer
between Japan and China. World J Gastroenterol. 17:4421–4428. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi YY, Noh SH and Cheong JH: Evolution
of gastric cancer treatment: From the golden age of surgery to an
era of precision medicine. Yonsei Med J. 56:1177–1185. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng P, Wu W, Zhao J, Song S, Wang X, Jia
D, Shao M, Zhang M, Li L, Wang L, et al: Decreased expression of
Calpain-9 predicts unfavorable prognosis in patients with gastric
cancer. Sci Rep. 6:296042016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garrido M, Fonseca PJ, Vieitez JM, Frunza
M and Lacave AJ: Challenges in first line chemotherapy and targeted
therapy in advanced gastric cancer. Expert Rev Anticancer Ther.
14:887–900. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takai Y, Ikeda W, Ogita H and Rikitake Y:
The immunoglobulin-like cell adhesion molecule nectin and its
associated protein afadin. Annu Rev Cell Dev Biol. 24:309–342.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yasumi M, Shimizu K, Honda T, Takeuchi M
and Takai Y: Role of each immunoglobulin-like loop of nectin for
its cell-cell adhesion activity. Biochem Biophys Res Commun.
302:61–66. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakanishi H and Takai Y: Roles of nectins
in cell adhesion, migration and polarization. Biol Chem.
385:885–892. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takai Y, Miyoshi J, Ikeda W and Ogita H:
Nectins and nectin-like molecules: Roles in contact inhibition of
cell movement and proliferation. Nat Rev Mol Cell Biol. 9:603–615.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reymond N, Fabre S, Lecocq E, Adelaïde J,
Dubreuil P and Lopez M: Nectin4/PRR4, a new afadin-associated
member of the nectin family that trans-interacts with nectin1/PRR1
through V domain interaction. J Biol Chem. 276:43205–43215. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fabre S, Reymond N, Cocchi F, Menotti L,
Dubreuil P, Campadelli-Fiume G and Lopez M: Prominent role of the
Ig-like V domain in trans-interactions of nectins. Nectin3 and
nectin 4 bind to the predicted C-C'-C'-D beta-strands of the
nectin1 V domain. J Biol Chem. 277:27006–27013. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fabre-Lafay S, Monville F, Garrido-Urbani
S, Berruyer-Pouyet C, Ginestier C, Reymond N, Finetti P, Sauvan R,
Adélaïde J, Geneix J, et al: Nectin-4 is a new histological and
serological tumor associated marker for breast cancer. BMC Cancer.
7:732007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fabre-Lafay S, Garrido-Urbani S, Reymond
N, Gonçalves A, Dubreuil P and Lopez M: Nectin-4, a new serological
breast cancer marker, is a substrate for tumor necrosis
factor-alpha-converting enzyme (TACE)/ADAM-17. J Biol Chem.
280:19543–19550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Athanassiadou AM, Patsouris E, Tsipis A,
Gonidi M and Athanassiadou P: The significance of Survivin and
Nectin-4 expression in the prognosis of breast carcinoma. Folia
Histochem Cytobiol. 49:26–33. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Derycke MS, Pambuccian SE, Gilks CB,
Kalloger SE, Ghidouche A, Lopez M, Bliss RL, Geller MA, Argenta PA,
Harrington KM and Skubitz AP: Nectin 4 overexpression in ovarian
cancer tissues and serum: Potential role as a serum biomarker. Am J
Clin Pathol. 134:835–845. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishiwada S, Sho M, Yasuda S, Shimada K,
Yamato I, Akahori T, Kinoshita S, Nagai M, Konishi N and Nakajima
Y: Nectin-4 expression contributes to tumor proliferation,
angiogenesis and patient prognosis in human pancreatic cancer. J
Exp Clin Cancer Res. 34:302015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma J, Sheng Z, Lv Y, Liu W, Yao Q, Pan T,
Xu Z, Zhang C and Xu G: Expression and clinical significance of
Nectin-4 in hepatocellular carcinoma. Onco Targets Ther. 9:183–190.
2016.PubMed/NCBI
|
|
22
|
Takano A, Ishikawa N, Nishino R, Masuda K,
Yasui W, Inai K, Nishimura H, Ito H, Nakayama H, Miyagi Y, et al:
Identification of nectin-4 oncoprotein as a diagnostic and
therapeutic target for lung cancer. Cancer Res. 69:6694–6703. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Liu S, Wang L, Wu Y, Hao J, Wang
Z, Lu W, Wang XA, Zhang F, Cao Y, et al: A novel PI3K/AKT signaling
axis mediates Nectin-4-induced gallbladder cancer cell
proliferation, metastasis and tumor growth. Cancer Lett.
375:179–189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jun KH, Lee JS, Kim JH, Kim JJ, Chin HM
and Park SM: The rationality of N3 classification in the 7th
edition of the International Union Against Cancer TNM staging
system for gastric adenocarcinomas: A case-control study. Int J
Surg. 12:893–896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ni S, Xu L, Huang J, Feng J, Zhu H, Wang G
and Wang X: Increased ZO-1 expression predicts valuable prognosis
in non-small cell lung cancer. Int J Clin Exp Pathol. 6:2887–2895.
2013.PubMed/NCBI
|
|
27
|
Qin HF, Qu LL, Liu H, Wang SS and Gao HJ:
Serum CEA level change and its significance before and after
Gefitinib therapy on patients with advanced non-small cell lung
cancer. Asian Pac J Cancer Prev. 14:4205–4208. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Chen Y, Wu M, Lan T, Wu Y, Li Y
and Qian H: Type II cyclic guanosine monophosphate-dependent
protein kinase inhibits Rac1 activation in gastric cancer cells.
Oncol Lett. 10:502–508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu G, Fan Z, Ding M, Zhang H, Mu L, Ding
Y, Zhang Y, Jia B, Chen L, Chang Z and Wu W: An EGFR/PI3K/AKT axis
promotes accumulation of the Rac1-GEF Tiam1 that is critical in
EGFR-driven tumorigenesis. Oncogene. 34:5971–5982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bousquet E, Calvayrac O, Mazières J,
Lajoie-Mazenc I, Boubekeur N, Favre G and Pradines A: RhoB loss
induces Rac1-dependent mesenchymal cell invasion in lung cells
through PP2A inhibition. Oncogene. 35:1760–1769. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jaffe AB and Hall A: Rho GTPases in
transformation and metastasis. Adv Cancer Res. 84:57–80. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takai Y, Sasaki T and Matozaki T: Small
GTP-binding proteins. Physiol Rev. 81:153–208. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Samanta D and Almo SC: Nectin family of
cell-adhesion molecules: Structural and molecular aspects of
function and specificity. Cell Mol Life Sci. 72:645–658. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sakisaka T, Ikeda W, Ogita H, Fujita N and
Takai Y: The roles of nectins in cell adhesions: Cooperation with
other cell adhesion molecules and growth factor receptors. Curr
Opin Cell Biol. 19:593–602. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rikitake Y, Mandai K and Takai Y: The role
of nectins in different types of cell-cell adhesion. J Cell Sci.
125:3713–3722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fuchs A and Colonna M: The role of NK cell
recognition of nectin and nectin-like proteins in tumor
immunosurveillance. Semin Cancer Biol. 16:359–366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fortugno P, Josselin E, Tsiakas K, Agolini
E, Cestra G, Teson M, Santer R, Castiglia D, Novelli G,
Dallapiccola B, et al: Nectin-4 mutations causing ectodermal
dysplasia with syndactyly perturb the rac1 pathway and the kinetics
of adherens junction formation. J Invest Dermatol. 134:2146–2153.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Henderson V, Smith B, Burton LJ, Randle D,
Morris M and Odero-Marah VA: Snail promotes cell migration through
PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent
pathways during prostate cancer progression. Cell Adh Migr.
9:255–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vial E, Sahai E and Marshall CJ: ERK-MAPK
signaling coordinately regulates activity of Rac1 and RhoA for
tumor cell motility. Cancer Cell. 4:67–79. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ray RM, Vaidya RJ and Johnson LR: MEK/ERK
regulates adherens junctions and migration through Rac1. Cell Motil
Cytoskeleton. 64:143–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
